Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110467555A reveals mild chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates. Enables cost reduction and supply chain reliability for global buyers.
Patent CN105294599B details a novel catalytic asymmetric synthesis for chiral thiadiazine diuretics. This method offers significant supply chain and cost advantages for pharmaceutical manufacturers.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Discover how this novel chiral catalyst enables 99% ee synthesis with 90% yield, reducing R&D costs and supply chain risks for oncology drug development.
Solve chiral drug synthesis challenges with metal-free catalysis. Achieve >99% ee, mild conditions, and scalable production for pharmaceutical intermediates. Reduce costs and supply chain risks.
Discover industrial-scale synthesis of axial chiral isopyrone-indole derivatives with 92% ee and 80% yield. Solve supply chain risks for anticancer drug development with mild reaction conditions.
Solve enantioselectivity challenges in asymmetric hydrogenation with tunable bisphosphine ligands. Achieve 92-99% ee, recyclable catalysts, and simplified synthesis for cost-effective API production.
Discover how this novel asymmetric catalytic hydrogenation method enables high-yield, high-ee synthesis of chiral dihydro-9-phenanthrene amine for pharmaceutical applications.
Solve low enantioselectivity & high cost in chiral indole synthesis. This patent's mild, scalable method delivers >90% ee & 98% yield for anti-tumor drug intermediates. Request COA now.
Solve low yield and safety issues in chiral indole synthesis. Our CDMO expertise delivers 90-95% ee and 64-98% yield for anti-tumor drug intermediates.
Efficient, high-yield synthesis of axial chiral indole-naphthalene compounds with >95% ee. Reduce R&D costs and supply chain risks for asymmetric catalysis applications.
Solve asymmetric synthesis challenges with 98:2 enantioselectivity and 86% yield. Reduce production costs and supply chain risks for cancer drug development.
Solve high-cost, low-yield challenges in chiral indole synthesis. This patent reveals a mild, scalable method with >90% ee and 98% yield for anti-cancer drug intermediates.
Tackle high Lefamulin production costs and low yields with emerging chiral synthesis. Discover efficient, green routes for pharmaceutical intermediates. Find reliable suppliers for scalable production.
Overcome flammable borane issues in S-beta-hydroxy-gamma-butyrolactone synthesis with new BiBr3-based process. Find reliable suppliers for pharma intermediates.
Struggling with low enantioselectivity in axial chiral indole synthesis? Discover emerging catalytic methods for high-purity compounds with 98:2 er. Find reliable suppliers for pharma R&D.